Network Reconstruction and Significant Pathway Extraction Using Phosphoproteomic Data from Cancer Cells
暂无分享,去创建一个
Aurélien Naldi | Ovidiu Radulescu | Marion Buffard | Peter J. Coopman | Romain M. Larive | Gilles Freiss
[1] B. Park,et al. Mutation of the PIK3CA oncogene in human cancers , 2006, British Journal of Cancer.
[2] K. Lukong,et al. Phosphoproteomics Analysis Identifies Novel Candidate Substrates of the Nonreceptor Tyrosine Kinase, Src-related Kinase Lacking C-terminal Regulatory Tyrosine and N-terminal Myristoylation Sites (SRMS) * , 2018, Molecular & Cellular Proteomics.
[3] Prahlad T. Ram,et al. NetWalker: a contextual network analysis tool for functional genomics , 2012, BMC Genomics.
[4] A. Pandey,et al. A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations , 2015, Proteomics.
[5] Hiroyuki Konishi,et al. The PIK3CA gene is mutated with high frequency in human breast cancers , 2004, Cancer biology & therapy.
[6] Aurélien Naldi,et al. Reconstruction and signal propagation analysis of the Syk signaling network in breast cancer cells , 2017, PLoS Comput. Biol..
[7] Y. Yun,et al. Discovery of gastric cancer specific biomarkers by the application of serum proteomics , 2017, Proteomics.
[8] S. Pervaiz,et al. Casein Kinase II: an attractive target for anti-cancer drug design. , 2010, The international journal of biochemistry & cell biology.
[9] Michael A. White,et al. Use of Data-Biased Random Walks on Graphs for the Retrieval of Context-Specific Networks from Genomic Data , 2010, PLoS Comput. Biol..
[10] P. Vogt,et al. Cancer-specific mutations in PIK3CA are oncogenic in vivo , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[11] Joon-Oh Park,et al. MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling , 2007, Science.
[12] David J. Lynn,et al. DyNet: visualization and analysis of dynamic molecular interaction networks , 2016, Bioinform..
[13] M. Le Borgne,et al. Topology and static response of interaction networks in molecular biology , 2006, Journal of The Royal Society Interface.
[14] T. Yagi,et al. A novel nonreceptor tyrosine kinase, Srm: cloning and targeted disruption , 1994, Molecular and cellular biology.
[15] Minoru Kanehisa,et al. KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..
[16] Eduardo Sontag,et al. Untangling the wires: A strategy to trace functional interactions in signaling and gene networks , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[17] Minoru Kanehisa,et al. New approach for understanding genome variations in KEGG , 2018, Nucleic Acids Res..
[18] Gary D. Bader,et al. Pathway Commons, a web resource for biological pathway data , 2010, Nucleic Acids Res..
[19] Bin Zhang,et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations , 2014, Nucleic Acids Res..
[20] A. Rivett,et al. Phosphorylation of 20S proteasome alpha subunit C8 (alpha7) stabilizes the 26S proteasome and plays a role in the regulation of proteasome complexes by gamma-interferon. , 2004, The Biochemical journal.
[21] Romain M. Larive,et al. Phosphoproteomic analysis of Syk kinase signaling in human cancer cells reveals its role in cell–cell adhesion , 2009, Oncogene.
[22] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[23] K. Lukong,et al. The unique N‐terminal region of SRMS regulates enzymatic activity and phosphorylation of its novel substrate docking protein 1 , 2013, The FEBS journal.
[24] K. Lukong,et al. Global phosphoproteomic analysis identifies SRMS-regulated secondary signaling intermediates , 2018, Proteome Science.
[25] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..
[26] Anna Ritz,et al. Pathways on demand: automated reconstruction of human signaling networks , 2016, npj Systems Biology and Applications.